Strategies to Continue Gynae-oncology Services in the Era of COVID-19 Outbreak: Concerns and Challenges in a Referral Centre in Malaysia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05043155

Enrollment

100

Registered

2021-09-14

Start date

2021-01-01

Completion date

2021-09-01

Last updated

2021-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Survivorship, Vaccination Refusal

Keywords

Covid19, Vaccination, Gynaeoncology cancer, Cancer survivor

Brief summary

A short survey involving 100 participants was conducted online to explore the understanding of Covid 19 pandemic impact and importance of vaccination among cancer survivors.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

Female cancer survivors or care-taker undergoing national covid 19 vaccine -

Exclusion criteria

Male, not cancer survivors \-

Design outcomes

Primary

Measure	Time frame	Description
Vaccination refusal	8 months	Number of cancer survivors refuse vaccine
Reason for Refusal of Vaccine	8 months	Number of cancer survivors refuse vaccine

Countries

Malaysia

Outcome results